Comparison of three methods of treatment in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with and without coronavirus positive test

Phase 2

Recruiting

• Conditions: Coronavirus disease (covid-19).; Other coronavirus as the cause of diseases classified elsewhere; B97.29

• Registration Number: IRCT20140305016852N4
• Lead Sponsor: Sabzevar University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 18 May 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

The patient was admitted to the acute respiratory center
Consent to participate in the study
Age 15 to above
Do not take vitamin C and D supplements
No gout
Lack of kidney and liver disease
No pregnancy or lactation
No treatment with anti convulsants

Exclusion Criteria

The patient has lung cancer
Patients undergoing chemotherapy and radiotherapy
If the patient dies
If the patient has a decreased level of consciousness
If the patient does not want to continue working on the plan

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Complete recovery of clinical symptoms of 2019 disease. Timepoint: About a week after starting treatment. Method of measurement: Clinical and laboratory questionnaire.;Normalization of chest symptoms in CT scan. Timepoint: About 7 to 14 days after starting treatment. Method of measurement: CT scan result.

Secondary Outcome Measures

Name	Time	Method
Improving and normalizing the level of laboratory symptoms. Timepoint: At least 1 to 2 weeks after starting treatment. Method of measurement: Laboratory techniques.